Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection

ConclusionsAn 8- or 12-week G/P regimen is highly effective and safe in GT2 HCV-infected hemodialysis patients.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research